Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TARSONS.NS Stock Summary
In the News
TARSONS.NS Financial details
Company Rating
-
Market Cap
29.44B
Income
699.99M
Revenue
2.77B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
713
Optionable
No
Shortable
Yes
Earnings
14 Aug 2023
P/E
42.23
Forward P/E
-
PEG
-13.02
P/S
10.64
P/B
5.19
P/C
-
P/FCF
-
Quick Ratio
2
Current Ratio
4.01
Debt / Equity
-
LT Debt / Equity
0.14
-
-
EPS (TTM)
13.15
EPS next Y
-
EPS next Q
-
EPS this Y
-22.05%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.67%
Revenue last 5Y
9.78%
Revenue Q/Q
-23.75%
EPS Q/Q
-58.04%
-
-
-
-
SMA20
5.64%
SMA50
-11.56%
SMA100
-1.45%
Inst Own
-
Inst Trans
-
ROA
10%
ROE
13%
ROC
0.15%
Gross Margin
76%
Oper. Margin
36%
Profit Margin
25%
Payout
-
Shs Outstand
53.21M
Shs Float
15.57M
-
-
-
-
Target Price
-
52W Range
501.1-847.95
52W High
-34.56%
52W Low
+10.63%
RSI
59
Rel Volume
0.33
Avg Volume
128.75K
Volume
42.19K
Perf Week
3.1%
Perf Month
-0.9%
Perf Quarter
-2.21%
Perf Half Y
3.96%
-
-
-
-
Beta
-
-
-
Volatility
11.9%, 13.63%
Prev Close
-1.26%
Price
554.25
Change
0.83%
TARSONS.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 34.88 | 34.3 | 44.74 | 57.83 | 53.24 | |
Net income per share | 7.65 | 7.94 | 13.52 | 19.46 | 15.17 | |
Operating cash flow per share | 10.08 | 12.59 | 13.38 | 16.13 | 14.21 | |
Free cash flow per share | 3.42 | 7.49 | 0.75 | -9.37 | -21.5 | |
Cash per share | 0.1 | 4.96 | 0.46 | 16.6 | 11.28 | |
Book value per share | 26.56 | 38.72 | 47.97 | 94.67 | 107 | |
Tangible book value per share | 26.56 | 38.72 | 47.85 | 94.54 | 106.9 | |
Share holders equity per share | 26.56 | 38.72 | 47.97 | 94.67 | 107 | |
Interest debt per share | 14.08 | 8.17 | 7.11 | 4.96 | 21.64 | |
Market cap | 41.69B | 41.75B | 41.69B | 36.37B | 28.31B | |
Enterprise value | 42.33B | 41.86B | 42B | 35.81B | 28.83B | |
P/E ratio | 107.01 | 103.02 | 60.53 | 36.13 | 35.08 | |
Price to sales ratio | 23.46 | 23.86 | 18.29 | 12.16 | 10 | |
POCF ratio | 81.2 | 65.02 | 61.17 | 43.57 | 37.45 | |
PFCF ratio | 239.54 | 109.26 | 1.09K | -74.99 | -24.76 | |
P/B Ratio | 30.82 | 21.13 | 17.06 | 7.43 | 4.97 | |
PTB ratio | 30.82 | 21.13 | 17.06 | 7.43 | 4.97 | |
EV to sales | 23.82 | 23.92 | 18.43 | 11.97 | 10.18 | |
Enterprise value over EBITDA | 54.74 | 57.3 | 38.63 | 22.26 | 20.35 | |
EV to operating cash flow | 82.45 | 65.19 | 61.63 | 42.91 | 38.14 | |
EV to free cash flow | 243.22 | 109.54 | 1.1K | -73.84 | -25.21 | |
Earnings yield | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | |
Free cash flow yield | 0 | 0.01 | 0 | -0.01 | -0.04 | |
Debt to equity | 0.48 | 0.18 | 0.14 | 0.04 | 0.19 | |
Debt to assets | 0.3 | 0.14 | 0.11 | 0.04 | 0.15 | |
Net debt to EBITDA | 0.83 | 0.15 | 0.29 | -0.35 | 0.36 | |
Current ratio | 1.8 | 2.96 | 2.7 | 7 | 4.01 | |
Interest coverage | 8.54 | 10.2 | 34.93 | 34.95 | 25.34 | |
Income quality | 0.92 | 1.21 | 0.74 | 0.62 | 0.7 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.66 | -0.4 | -0.94 | -1.58 | -2.51 | |
Capex to revenue | -0.19 | -0.15 | -0.28 | -0.44 | -0.67 | |
Capex to depreciation | -2.33 | -1.83 | -4.71 | -6.01 | -6.66 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 67.6 | 83.2 | 120.79 | 203.58 | 191.11 | |
ROIC | 0.21 | 0.19 | 0.25 | 0.2 | 0.12 | |
Return on tangible assets | 0.18 | 0.16 | 0.23 | 0.19 | 0.11 | |
Graham Net | -3.01 | 6.45 | -5.09 | 24.72 | 1.91 | |
Working capital | 430.85M | 794.06M | 710.03M | 2.1B | 1.89B | |
Tangible asset value | 1.35B | 1.98B | 2.44B | 4.89B | 5.69B | |
Net current asset value | 204.29M | 687.09M | 611.9M | 1.9B | 956.53M | |
Invested capital | 0.48 | 0.18 | 0.14 | 0.04 | 0.19 | |
Average receivables | 0 | 479.84M | 229.03M | 368.07M | 697M | |
Average payables | 0 | 39.62M | 59.4M | 94.64M | 113M | |
Average inventory | 0 | 475.88M | 477.13M | 645.36M | 983.74M | |
Days sales outstanding | 103.04 | 95.55 | 0 | 89.8 | 84.77 | |
Days payables outstanding | 11.8 | 36.81 | 29.36 | 59.05 | 54.13 | |
Days of inventory on hand | 271.53 | 303.73 | 229.46 | 375.53 | 641.72 | |
Receivables turnover | 3.54 | 3.82 | 0 | 4.06 | 4.31 | |
Payables turnover | 30.92 | 9.92 | 12.43 | 6.18 | 6.74 | |
Inventory turnover | 1.34 | 1.2 | 1.59 | 0.97 | 0.57 | |
ROE | 0.29 | 0.21 | 0.28 | 0.21 | 0.14 | |
Capex per share | -6.66 | -5.1 | -12.63 | -25.51 | -35.7 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q1
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 12.91 | 13.38 | 11.53 | 15.42 | 11.74 | |
Net income per share | 3.82 | 4.03 | 3.03 | 4.29 | 1.8 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 11.81 | 0 | 11.28 | 0 | |
Book value per share | 0 | 99.85 | 0 | 107 | 0 | |
Tangible book value per share | 0 | 99.85 | 0 | 106.9 | 0 | |
Share holders equity per share | 0 | 99.85 | 0 | 107 | 0 | |
Interest debt per share | 0 | 11.71 | 0 | 21.19 | 0 | |
Market cap | 38.03B | 43.43B | 36.94B | 28.31B | 32.11B | |
Enterprise value | 0 | 43.42B | 0 | 28.83B | 0 | |
P/E ratio | 46.81 | 50.59 | 57.3 | 31.01 | 83.65 | |
Price to sales ratio | 55.41 | 60.96 | 60.24 | 34.51 | 51.32 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 8.17 | 0 | 4.97 | 0 | |
PTB ratio | 0 | 8.17 | 0 | 4.97 | 0 | |
EV to sales | 0 | 60.95 | 0 | 35.14 | 0 | |
Enterprise value over EBITDA | 0 | 119.27 | 0 | 69.59 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.01 | 0 | 0 | 0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.12 | 0 | 0.19 | 0 | |
Debt to assets | 0 | 0.1 | 0 | 0.15 | 0 | |
Net debt to EBITDA | 0 | -0.03 | 0 | 1.25 | 0 | |
Current ratio | 0 | 3.11 | 0 | 4.01 | 0 | |
Interest coverage | 64.11 | 40.16 | 18.51 | 16.04 | 6.34 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 95.15 | 0 | 101.62 | 0 | |
ROIC | 0 | 0.04 | 0 | 0.04 | 0 | |
Return on tangible assets | 0 | 0.03 | 0 | 0.03 | 0 | |
Graham Net | 0 | 11.09 | 0 | 1.91 | 0 | |
Working capital | 0 | 1.58B | 0 | 1.89B | 0 | |
Tangible asset value | 0 | 5.31B | 0 | 5.69B | 0 | |
Net current asset value | 0 | 1.37B | 0 | 956.53M | 0 | |
Invested capital | 0 | 0.12 | 0 | 0.19 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 73.14 | 0 | 72.16 | 0 | |
Days payables outstanding | 0 | 50.4 | 0 | 42.69 | 0 | |
Days of inventory on hand | 0 | 538.2 | 0 | 506.1 | 0 | |
Receivables turnover | 0 | 1.23 | 0 | 1.25 | 0 | |
Payables turnover | 0 | 1.79 | 0 | 2.11 | 0 | |
Inventory turnover | 0 | 0.17 | 0 | 0.18 | 0 | |
ROE | 0 | 0.04 | 0 | 0.04 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
TARSONS.NS Frequently Asked Questions
What is Tarsons Products Limited stock symbol ?
Tarsons Products Limited is a IN stock and trading under the symbol TARSONS.NS
What is Tarsons Products Limited stock quote today ?
Tarsons Products Limited stock price is $554.25 today.
Is Tarsons Products Limited stock public?
Yes, Tarsons Products Limited is a publicly traded company.